Bot Detector
LEARN MORE
A subscription to
IJPC
provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.
LEARN MORE
Sign On
The Journal
Editor-In-Chief
Editorial Calendar
Submissions
Advertising
Permissions & Reprints
Privacy Policy
Contact Us
Subscribe
Renew
Prices
Free Sample
View Cart
Articles
Issues
Archives
Supplemental Content and Errata
Training and Education
IJPC-PCAB SOP Matrix
USP GAP Analysis
Compounders' Network List
Patient Information
Videos
Compounders' Resource Directory
Sep/Oct 2022 - Volume 26, Number 5
Purchase the entire back issue in electronic PDF or print format.
(Select Format)
PDF — $95
Print Copy — $95
Purchase individual articles by selecting the article in the table below...
Individual Articles - Sep/Oct 2022 - Volume 26, Number 5
Title/Author
(Click for Abstract / Details / Purchase)
Issue/Page
View/Buy
PreScription: A New Dosage Form
Allen Loyd V Jr
Sep/Oct 2022
Pg. 356
Hazardous Drug Enteral Device: A Closed System Device for Crushing and Dispersing Hazardous Drug Tablets for Enteral Administration
Lopez C Vidal
,
Rios GL Quito
Sep/Oct 2022
Pg. 358-362
A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans
Riepl Mike
Sep/Oct 2022
Pg. 364-368
Recent Formulation Advances and Preparation of Orally Disintegrating Tablets
Ejeta Fikadu
Sep/Oct 2022
Pg. 370-377
Compounded Medications and Probiotics for Irritable Bowel Syndrome
Narváez Katherine Rivera
,
Thompson Tara
Sep/Oct 2022
Pg. 378-384
Compounding with Biotechnology Products, Part 1: General Considerations
Allen Loyd V Jr
Sep/Oct 2022
Pg. 385-395
The FDA is in a Hole. It Should Stop Digging.
Brunner Scott
Sep/Oct 2022
Pg. 396-398
Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview
Allen Loyd V Jr
Sep/Oct 2022
Pg. 400-408
Sterile Basics of Compounding: Contamination Control Strategies, Part 1
Summers Amy
Sep/Oct 2022
Pg. 411-418
Calculations
Stockton Shelly J
Sep/Oct 2022
Pg. 420
Amphotericin B 3% Otic Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 422
Ascorbic acid 5% Topical Microemulsion
Allen Loyd V Jr
Sep/Oct 2022
Pg. 423
Chlorhexidine Diacetate 2% Topical Gel
Allen Loyd V Jr
Sep/Oct 2022
Pg. 424
Clindamycin Hydrochloride 10-mg/mL Oral Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 425
Clotrimazole 10-mg Troches
Allen Loyd V Jr
Sep/Oct 2022
Pg. 426
Cysteamine Hydrochloride 100 mg/mL Oral Solution
Allen Loyd V Jr
Sep/Oct 2022
Pg. 427
Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse
Allen Loyd V Jr
Sep/Oct 2022
Pg. 428
Lansoprazole 3-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2022
Pg. 429
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment
Allen Loyd V Jr
Sep/Oct 2022
Pg. 430
Methylcobalamin 2-mg/mL Nasal Spray
Allen Loyd V Jr
Sep/Oct 2022
Pg. 431
Effectiveness of a New Ultraviolet C Disinfection System to Inactivate Airborne Coronavirus in Different Environmental Conditions
Marianni Bruna
,
Polonini Hudson
Sep/Oct 2022
Pg. 432-435
Effects of Calcium Polystyrene Sulfonate Formulation Change from Dry Syrup to Oral Solution in Patients with Chronic Kidney Disease
Kobayashi Shunsuke
,
Ogawara Yuka
,
Imamura Yoshihiko
,
Kitaoka Akira
,
Yasu Takeo
Sep/Oct 2022
Pg. 436-439
Return to Top